These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10905886)

  • 1. The chronic disease of childhood obesity: the sleeping giant has awakened.
    Sokol RJ
    J Pediatr; 2000 Jun; 136(6):711-3. PubMed ID: 10905886
    [No Abstract]   [Full Text] [Related]  

  • 2. [Common biochemical changes in obesity related liver diseases].
    Gao CF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):433. PubMed ID: 15268812
    [No Abstract]   [Full Text] [Related]  

  • 3. Can an increase of body mass index by 1 kg/m(2) be a risk for obesity-related diseases?
    Saibara T
    J Gastroenterol; 2003; 38(10):1022-3. PubMed ID: 14614617
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ursodeoxycholic acid lowers liver enzymes].
    Leuschner U
    Leber Magen Darm; 1989 Sep; 19(5):276. PubMed ID: 2811579
    [No Abstract]   [Full Text] [Related]  

  • 5. [Should we do a liver puncture biopsy in patients with chronic "unexplained" cytolyses?].
    De Lédinghen V
    Gastroenterol Clin Biol; 2002; 26(8-9):724-7. PubMed ID: 12434076
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interpretation of hypertransaminasemia].
    Othmani S; Bahri M; Bahri M
    Tunis Med; 2002 May; 80(5):236-44. PubMed ID: 12534025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiologies of a moderate and prolonged elevation of serum activity of transaminases: the end of "transaminitis"?].
    Bastie A; Capron JP
    Gastroenterol Clin Biol; 1993; 17(1):33-6. PubMed ID: 8467968
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of hypertransaminasemia in blood donors. Study performed in patients of the Saint Thomas Hospital].
    Narváez E; de Lozano D; Perez Ferrari R
    Rev Med Panama; 1983 Jan; 8(1):45-9. PubMed ID: 6828781
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver findings in primary hyperlipoproteinemia (HLP)].
    Renger F; Hanefeld M; Jaross W; Stötzner H; Kemmer C; Leonhardt W; Trübsbach A; Schentke KU
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):199-203. PubMed ID: 4365203
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children.
    Lykavieris P; Ducot B; Lachaux A; Dabadie A; Broué P; Sarles J; Bernard O; Jacquemin E
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):623-9. PubMed ID: 18955864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic trial with methylphenobarbital (Prominal), an enzyme inducer, in liver disease. A contribution to the question of hepatotoxicity of barbiturates.
    Glogner P; Massarrat S; Henrichs HR
    Acta Hepatosplenol; 1971; 18(5):394-7. PubMed ID: 5112056
    [No Abstract]   [Full Text] [Related]  

  • 12. Is aspartate aminotransferase enough?
    Giannini E; Testa R
    Am J Gastroenterol; 2000 Dec; 95(12):3687-8. PubMed ID: 11151945
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis of hepatosis].
    Nöcker J; Hartleb O; Weidemann H
    Dtsch Z Verdau Stoffwechselkr; 1966 Feb; 25(6):349-54. PubMed ID: 5998358
    [No Abstract]   [Full Text] [Related]  

  • 14. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
    Papatheodoridis GV; Goulis J; Christodoulou D; Manolakopoulos S; Raptopoulou M; Andrioti E; Alexandropoulos N; Savvidou S; Papachristou A; Zervou E; Seferiadis K; Kousidou P; Vogiatzakis E; Tsianos E
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
    Lindor KD; Kowdley KV; Heathcote EJ; Harrison ME; Jorgensen R; Angulo P; Lymp JF; Burgart L; Colin P
    Hepatology; 2004 Mar; 39(3):770-8. PubMed ID: 14999696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background.
    Kojima S; Watanabe N; Numata M; Ogawa T; Matsuzaki S
    J Gastroenterol; 2003; 38(10):954-61. PubMed ID: 14614602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease in patients treated with chronic hemodialysis.
    Ivey KJ; Clifton JA
    Gastroenterology; 1970 Oct; 59(4):630-4. PubMed ID: 5477756
    [No Abstract]   [Full Text] [Related]  

  • 18. The prevalence of obesity and elevated liver enzymes in children at a university gastroenterology clinic.
    Elitsur Y; Lawrence Z
    W V Med J; 2004; 100(2):67-9. PubMed ID: 15239378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle advice in non-alcoholic fatty liver disease.
    Manco M; Marcellini M; Nobili V
    J Gastroenterol Hepatol; 2007 Apr; 22(4):604-5. PubMed ID: 17376064
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent hyperaminotransferasemia resolving after weight reduction in obese children.
    Vajro P; Fontanella A; Perna C; Orso G; Tedesco M; De Vincenzo A
    J Pediatr; 1994 Aug; 125(2):239-41. PubMed ID: 8040771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.